Portfolio company
Alcolase
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This biotech company develops enzyme supplements for individuals with alcohol intolerance and ALDH2 deficiency to break down alcohol before it enters the bloodstream.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Kiwi Biosciences
The company develops digestive enzyme supplements to help individuals with irritable bowel syndrome and food intolerances break down problematic carbohydrates.
ZBiotics
This company produces genetically engineered probiotics, including a pre-alcohol drink, for health-conscious consumers who want to mitigate the effects of drinking.
Amygdala Neurosciences
This biopharmaceutical company develops oral enzyme inhibitors to treat substance use disorders by reducing cravings and preventing relapse in patients.
Prozymi Biolabs
This company develops enzyme technology for food manufacturers to create gluten-safe wheat products for consumers with coeliac disease and gluten sensitivities.
Amplifye
This biotechnology company develops precision enzymes to enhance protein absorption and nutritional efficiency for the food, supplement and animal feed industries.
ALLOX
This company develops a computational and experimental platform to identify allosteric sites in proteins for pharmaceutical companies and researchers to design new drugs.
Phenotap
This company develops enzymes for blood glucose and ketone monitoring device manufacturers to enable continuous metabolic tracking and diabetic ketoacidosis detection.
ALTR
This company develops nanofiltration technology to remove alcohol at a molecular level for beverage manufacturers and winemakers.
